GlassScriptPhysician profile
Susan Wg Batten
NPI 1033732375
$3,220.64
in general payments reported to CMS, 2019-2025
23 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what 89% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $507 · 2023: $694 · 2024: $829 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,573.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $511.22 | 2023-2025 | |
| Inspire Medical Systems, INC. | $324.33 | 2023-2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $283.83 | 2022-2025 | Austedo Xr, Austedo Xr |
| Jazz Pharmaceuticals INC. | $250.00 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $197.23 | 2022-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $163.39 | 2022-2024 | |
| Eisai INC. | $124.94 | 2024 | |
| Argenx US, INC. | $124.56 | 2025 | Vyvgart |
| Madrigal Pharmaceuticals | $124.04 | 2025 | Rezdiffra |
| Axsome Therapeutics, INC. | $123.23 | 2025 | Symbravo |
| Alexion Pharmaceuticals, INC. | $120.89 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $119.70 | 2025 | Lumryz |
| Ipsen Biopharmaceuticals, INC | $90.95 | 2025 | Iqirvo |
| Otsuka America Pharmaceutical, INC. | $90.69 | 2025 | Rexulti |
| Corcept Therapeutics | $88.80 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $82.17 | 2024 | Mounjaro |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $78.92 | 2022 | |
| Alkermes, INC. | $68.44 | 2023 | Lybalvi |
| Harmony Biosciences LLC | $63.54 | 2022 | |
| Aimmune Therapeutics, INC. | $60.59 | 2025 | Zenpep |
| Amgen INC. | $50.77 | 2021 | |
| Atricure, INC. | $40.42 | 2024 | |
| Silk Road Medical, INC. | $37.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Batten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.